Search

(GlobeNewswire) - Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ('Ainos', or the 'Company'), a diversified healthcare company focused on novel AI-powered point-of-care testing ('POCT') and VELDONA low-dose interferon therapeutics, today announced that its AI [...]

DUBLIN, Oct. 18, 2023 /PRNewswire/ -- The https://www.researchandmarkets.com/reports/5308214/global-latent-tuberculosis-infection-ltbi?utm_source=CI&utm_medium=PressRelease&utm_code=7ch6fh&utm_campaign=1900251+-+Innovative+Line+Probe+Assays+(LPAs)+Transform+Drug-Resistant+Tuberculosis+Diagnosis+in+LTBI+Testing+Market&utm_exec=jamu273prd report has been added toResearchAndMarkets.com's offering. Latent tuberculosis, a condition where tuberculosis bacteria remain dormant within the body, presents a unique challenge [...]

NEW YORK, United States, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Zion Market Research has published a new research report titled 'https://www.globenewswire.com/Tracker?data=5FsgyGugDG56M0W_zecYlaRZtA-svvWGuqj0K2yxfuSlZOcBRUvQva1tiBp4r2-XLPOKfVburlUMHuIDmrsO4MGlplXOgOUJ-O0qZ4SJfzqjIcvm9LUWLHUTxCZkVsGuL48aEfO57H_juR7PaPfqOS-C1NTd-M0InFmLG3eUPjqPd3Neo4vxgJHS-qjdMkYC By Application (Diagnostic Laboratories, Hospitals, Pharmaceutical & Biotechnology Companies, [...]

VELDONA interferon-alpha formulation has shown potential as a treatment candidate for feline chronic gingivostomatitis and canine atopic dermatitis Ainos advances its product pipeline as it targets commencing clinical studies during [...]

The FDA gave positive feedback regarding filing a Biologics License Application (BLA) for Sjögren's syndrome following two Phase 3 studies Ainos is seeking out-licensing opportunities to accelerate the process of [...]

LONDON, Sept. 13, 2022 /PRNewswire/ --Global https://brandessenceresearch.com/pharmaceutical/bio-pharma-market is valued atUSD 274.10 Billion in 2020 and is expected to reachUSD 703.28 Billion by 2027 with aCAGR of 12.5% over the forecast [...]

Hamsters Receiving Ainos' VELDONA Formulation Demonstrate Protection from COVID-19 Based on Prespecified Indicators of Clinical Outcomes SAN DIEGO, June 27, 2022 /PRNewswire/ -- Ainos, Inc. (OTC PINK: AIMD) ('Ainos', or [...]

(GlobeNewswire) - Latest research report on Biosimilar Pipeline Market by Product (Human Growth Hormone, Interferon, Insulin, Monoclonal Antibodies, Peptides, Others); by Service (Contract Research and Manufacturing, Clinical Trials); by Applications [...]

PLEASANTON CA, Nov 02, 2021 (GLOBE NEWSWIRE via COMTEX) -- Latest research report on 'Biosimilar Pipeline Market by Product (Human Growth Hormone, Interferon, Insulin, Monoclonal Antibodies, Peptides, Others); by Service [...]

M2 PRESSWIRE-September 20, 2021-: Hepatitis Therapeutics Markets: Interferon, Monoclonal Antibody, Non-structural protein 5A (NS5A) inhibitors, Others - Global Forecast to 2027 (C)1994-2021 M2 COMMUNICATIONS RDATE:20092021 The 'Hepatitis Therapeutics Market, By [...]

NEW YORK, June 29, 2020 /PRNewswire/ --This report is 80% complete and can be delivered within three working days post order confirmation and will include the latest impact analysis of [...]

DUBLIN -- The 'Biosimilars Market by Product (Insulin, Interferon, Etanercept, Infliximab, Rituximab, Glucagon, Calcitonin), Manufacturing (In-house, Contract) & Indication (Oncology, Chronic Disease, Blood Disorder, Autoimmune Disease), Region - Global Forecast [...]

M2 PRESSWIRE-March 30, 2020-: Outlook on the Worldwide Biosimilars Market to 2025 - Featuring Sandoz, Pfizer, Eli Lilly & Teva Pharmaceutical Among Others (C)1994-2020 M2 COMMUNICATIONS RDATE:30032020 The 'Biosimilars Market [...]

New Delhi, April 11 -- The latest trending report Global Interferon Alpha-2a Biosimilar Market by Manufacturers, Regions, Type and Application, Forecast to 2024 offered by DecisionDatabases.com is an informative study [...]

India, Oct. 25 -- 25th October, 2018- Interferon Market expected to grow at a significant CAGR in the upcoming years as the scope and its applications are rising enormously across [...]

India, Oct. 25 -- Interferon Market expected to grow at a significant CAGR in the upcoming years as the scope and its applications are rising enormously across the globe. Interferon [...]

NEW YORK, May 23, 2017 /PRNewswire/ -- Highlights Biosimilars Market by Product (Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon), glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin)), Manufacturing (In-House, CM0) & Application (Oncology, [...]

M2 PRESSWIRE-September 5, 2016-: Infectious Disease Treatment Market in China 2016-2020 - Emergence of Interferon Free Therapies (C)1994-2016 M2 COMMUNICATIONS RDATE:05092016 Dublin - Research and Markets has announced the addition [...]

DUBLIN -- Research and Markets has announced the addition of the 'Infectious Disease Treatment Market in China 2016-2020' report to their offering. The report forecasts the infectious disease treatment market [...]

M2 PRESSWIRE-July 23, 2014-: World Market for Biosimilars (EPO, G-CSF, HGH, Insulin, Interferon alpha, mAbs, Others) 2013-2017 (C)1994-2014 M2 COMMUNICATIONS RDATE:23072014 Dublin - Research and Markets (http://www.researchandmarkets.com/research/tpvpdw/the_world_market) has announced the [...]

Jul 23, 2014 (M2 PRESSWIRE via COMTEX) -- Research and Markets (http://www.researchandmarkets.com/research/tpvpdw/the_world_market) has announced the addition of the 'The World Market for Biosimilars, 4th Edition (EPO, G-CSF, HGH, Insulin, Interferon [...]

LONDON, July 21, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: https://www.reportbuyer.com/product/2076279/The-World-Market-for-Biosimlars-(EPO-G-CSF-HGH-Insulin-Interferon-Alpha-Monoclonal-Antibodies-Other)-4th-Edition.html#utm_source=prnewswire https://www.reportbuyer.com/product/2076279/The-World-Market-for-Biosimlars-EPO-G-CSF-HGH-Insulin-Interferon-Alpha-Monoclonal-Antibodies-Other-4th-Edition.html This study, The World Market for Biosimilars, 4th Edition (EPO, G-CSF, HGH, Insulin, Interferon [...]

M2 PRESSWIRE-June 6, 2014-: The World Market for Biosimilars 2013-2017 - EPO, G-CSF, HGH, Insulin, Interferon Alpha, Monoclonal Antibodies (C)1994-2014 M2 COMMUNICATIONS RDATE:06062014 Dublin - Research and Markets (http://www.researchandmarkets.com/research/7brbq6/the_world_market) has [...]

DUBLIN -- Research and Markets (http://www.researchandmarkets.com/research/xp9knh/the_world_market) has announced the addition of the 'The World Market for Biosimilars (EPO, G-CSF, HGH, Insulin, Interferon Alpha, Monoclonal Antibodies, Other), 4th Edition' report to [...]

Jun 06, 2014 (M2 PRESSWIRE via COMTEX) -- Research and Markets (http://www.researchandmarkets.com/research/7brbq6/the_world_market) has announced the addition of the 'The World Market for Biosimilars (EPO, G-CSF, HGH, Insulin, Interferon Alpha, Monoclonal [...]

NEW YORK, April 22, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: http://www.reportlinker.com/p02076279/The-World-Market-for-Biosimlars-(EPO-G-CSF-HGH-Insulin-Interferon-Alpha-Monoclonal-Antibodies-Other)-4th-Edition.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Biopharmaceutical http://www.reportlinker.com/p02076279/The-World-Market-for-Biosimlars-EPO-G-CSF-HGH-Insulin-Interferon-Alpha-Monoclonal-Antibodies-Other-4th-Edition.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Biopharmaceutical This study, The World Market for Biosimilars, 4th [...]

M2 PRESSWIRE-April 16, 2014-: World Market for Biosimilars to 2017: EPO, G-CSF, HGH, Insulin, Interferon alpha, mAbs, Others (C)1994-2014 M2 COMMUNICATIONS RDATE:16042014 Dublin - Research and Markets (http://www.researchandmarkets.com/research/5qb5x5/the_world_market) has announced [...]

DUBLIN -- Research and Markets (http://www.researchandmarkets.com/research/xgx3p4/the_world_market) has announced the addition of the 'The World Market for Biosimilars, 4th Edition (EPO, G-CSF, HGH, Insulin, Interferon alpha, mAbs, Others)' report to their [...]

Apr 16, 2014 (M2 PRESSWIRE via COMTEX) -- Research and Markets (http://www.researchandmarkets.com/research/5qb5x5/the_world_market) has announced the addition of the 'The World Market for Biosimilars, 4th Edition (EPO, G-CSF, HGH, Insulin, Interferon [...]

M2 PRESSWIRE-May 15, 2013-: The Hepatitis C Market Forecast to 2022 - Revolutionary Interferon-Free Regimens Arrive(C)1994-2013 M2 COMMUNICATIONS RDATE:15052013 Dublin - Research and Markets (http://www.researchandmarkets.com/research/jxbt2k/the_hepatitis_c) has announced the addition of [...]

DUBLIN -- Research and Markets (http://www.researchandmarkets.com/research/b28wl6/the_hepatitis_c) has announced the addition of the 'The Hepatitis C Market Forecast to 2022' report to their offering. The hepatitis C market is set to [...]

May 15, 2013 (M2 PRESSWIRE via COMTEX) -- Research and Markets (http://www.researchandmarkets.com/research/zk5xkd/avonex_multiple) has announced the addition of the 'Avonex (Multiple Sclerosis) - Forecast and Market Analysis to 2022' report to [...]

May 15, 2013 (M2 PRESSWIRE via COMTEX) -- Research and Markets (http://www.researchandmarkets.com/research/wc4bng/betaseronbetafero) has announced the addition of the 'Betaseron/Betaferon (Multiple Sclerosis) - Forecast and Market Analysis to 2022' report to [...]

May 14, 2013 (M2 PRESSWIRE via COMTEX) -- Research and Markets (http://www.researchandmarkets.com/research/4t9gzl/nu100_multiple) has announced the addition of the 'NU-100 (Multiple Sclerosis) - Forecast and Market Analysis to 2022' report to [...]

May 14, 2013 (M2 PRESSWIRE via COMTEX) -- Research and Markets (http://www.researchandmarkets.com/research/rf3vwm/rebif_multiple) has announced the addition of the 'Rebif (Multiple Sclerosis) - Forecast and Market Analysis to 2022' report to [...]

Research and Markets has announced the addition of the 'The Hepatitis C Market Forecast to 2022' report to its offerings. In a release, Research and Markets noted that report highlights [...]